Diseases, Conditions, Syndromes

Swiss giant Novartis halts COVID-19 hydroxychloroquine study

Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.

Diseases, Conditions, Syndromes

Students' mental health deteriorating during pandemic

Since the COVID-19 pandemic struck last March, psychiatric emergency visits at Rady Children's Hospital near San Diego have crept up as youths and teens struggle with virtual learning, social isolation and unstable home lives.

page 1 from 8